https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/05/Opal-Sandy-gene-therapy-trial.jpg
600
600
cbrcprod
https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/04/Cambridge_BRC_NIHR_logo.png
cbrcprod2024-05-09 10:37:592025-01-10 18:00:08Baby born deaf can hear after breakthrough gene therapyThe NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
We've launched lots of exciting funding and development opportunities in the last week!
Find them below 👇 or visit our website to see the full list of opportunities available: https://www.nihr.ac.uk/funding-opportunities
⏳ Final call: Applications are closing soon for Non-Executive Members of our new Council!
Help shape the strategic direction of health and care research in the UK. Apply by 10 April, 1pm ➡️https://www.nihr.ac.uk/honorary-and-specialty/nihr-council-non-executive-council-members
Many congratulations Sadaf from your colleagues at @IMS_MRL, @Cambridge_Uni, @CUH_NHS, @CambridgeBRC. Very well deserved
More details
👇
https://www.mrl.ims.cam.ac.uk/news/obesity-prize-excellence-awarded-professor-sadaf-farooqi-distinguished-and-innovative-work

















Evaluation of a simple risk score to predict preterm pre-eclampsia using maternal characteristics: a prospective cohort study.
A lower maternal cortisol to cortisone ratio precedes clinical diagnosis of preterm and term preeclampsia by many weeks
Age at Menarche and Blood Pressure in Pregnancy
HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes and Childhood Glucose Metabolism
Mixed-meal tolerance test to assess residual beta-cell secretion: Beyond the area-under-curve of plasma C-peptide concentration.